Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Oncodesign Services has appointed Dr. Aidan Synnott as chief executive officer, to help strengthen its position as a trusted partner in drug discovery. The appointment reflects the company’s commitment to deepen client collaboration, enhance the ...
read more
CluePoints announced Usama Dar as its new Chief Product and Technology Officer. Having led both product and R&D teams through significant expansion, Usama is ideally placed to help CluePoints in the next phase of its growth journey.
read more
Evestia Clinical, the new identity of EMAS Pharma, has launched as a provider of clinical research in oncology and rare diseases globally.
read more
Kindeva has appointed Daniel J. Speciale as Chief Financial Officer (CFO) to strengthen its executive leadership team and drive financial strategy across the organization.
read more
George Clinical announced it has rebranded to become Emerald Clinical Trials. This strategic name change underscores the company's well-established position as a dedicated, reliable, consistent, and flexible CRO, while mitigating global clinical ...
read more
Curium Pharma, a provider of nuclear medicine services, announces the successful completion of its acquisition of Eczacibasi-Monrol Nuclear Products Co. (Monrol), a prominent player in nuclear medicine based in Istanbul, Turkey.
read more
Singota Solutions has opened a new 100,000 square-foot pharmaceutical storage and logistics facility in Balerna, Switzerland.
read more
Shanghai Henlius Biotech, Inc. and Organon announced that the European Medicines Agency (EMA) has validated the marketing authorization application (MAA) for HLX11, an investigational biosimilar of Perjeta® (pertuzumab). Pertuzumab has been approved ...
read more
TFS HealthScience (TFS), a global contract research organization (CRO), announced the appointment of long-standing member of the company, Miriam Martin , as Vice President of Business Development, Clinical Development Services (CDS).
read more
Adams Clinical Site Network, a Neuroscience-focused clinical trial site network announced today that Dr. Colin Sauder, PhD has joined the company as Chief Scientific Officer. In his role, Dr. Sauder will oversee clinical and operational teams ...
read more
underwent a cGMP (Current Good Manufacturing Practices) on-site inspection by the FDA and received the EIR (Establishment Inspection Report) from the FDA. This is the fourth time that Langhua Pharmaceutical has undergone and passed the on-site ...
read more
Scinai Immunotherapeutics Ltd., a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and in providing CDMO services through its Scinai Bioservices unit, announced that it has entered into a binding option ...
read more
CDI Labs Canada Inc., a provider of services for proteome-wide antibody profiling and target identification, announced the launch of its Technology Access Program for custom peptide libraries for serum antibody analysis services.
read more
Oregon Freeze Dry Life Sciences announced multiple leadership appointments to its recently created Life Sciences division and the appointment of CDMO veteran Jim Miller to its board of directors.
read more
Thermo Fisher Scientific Inc. has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute). This agreement aims to develop new technologies to enable researchers to better ...
read more